Assumptions Regarding Cancer Risk Require Constant Reevaluation

Maurie Markman, MD
Published: Sunday, Oct 01, 2017
Maurie Markman, MD
Maurie Markman, MD
Oncologists are well aware that by the time a new antineoplastic drug or regimen first enters the pages of a traditional reference textbook, the data supporting its use, including doses, schedules, and clinical indications, may already be considerably out-of-date. This is the result of the rapid acceleration in the rate of knowledge generation at both the preclinical and clinical levels in oncology. Consequently, data provided in abstracts presented at major national or international cancer meetings and in peer-reviewed journal articles are often more relevant to the practicing physician than material found within oncology textbooks.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances In™ Tumor Testing: Interpreting Genomic Profiles to Optimize Breast Cancer TreatmentJun 29, 20191.5
Community Practice Connections™: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for NursesJun 29, 20191.5
Publication Bottom Border
Border Publication
x